EyePoint Pharmaceuticals Inc

EyePoint Pharmaceuticals Inc

Health CarePharmaceuticals & Biotechnology
  • Price (USD)1.42
  • Today's Change-0.05 / -3.40%
  • Shares traded629.35k
  • 1 Year change-30.73%
  • Beta1.7065
Data delayed at least 15 minutes, as of Nov 14 2019 21:00 GMT.
More ▼

Events & Activity

  • EYPT:NMQ price moved over +5.44% to 1.55
  • EYPT:NMQ trading volume exceeds daily average by +15.13%

Key statistics

On Thursday, EyePoint Pharmaceuticals Inc (EYPT:NMQ) closed at 1.42, 19.33% above the 52 week low of 1.19 set on Aug 06, 2019.
52-week range
1.19Aug 06 20192.82Feb 14 2019
Markit short selling activity
Previous close1.42
Average volume866.60k
Shares outstanding108.12m
Free float107.33m
P/E (TTM)--
Market cap153.53m USD
EPS (TTM)-0.8515
Data delayed at least 15 minutes, as of Nov 14 2019 21:00 GMT.
More ▼
The Financial and Risk business of Thomson Reuters is now Refinitiv
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.